Region:Global
Product Code:99SGL298Lif2019000017093
Snapshot
The global Next Generation Cancer Diagnostics market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Next Generation Cancer Diagnostics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Others
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals
Clinics
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Next Generation Cancer Diagnostics Industry
1.1.1 Overview
1.1.2 Development of Next Generation Cancer Diagnostics
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Next Generation Cancer Diagnostics Market by Type
3.1 By Type
3.1.1 Next Generation Sequencing
3.1.2 qPCR & Multiplexing
3.1.3 DNA Microarrays
3.1.4 Others
3.2 Market Size
3.3 Market Forecast
4 Major Companies List
4.Next Generation Cancer Diagnostics Cepheid (Company Profile, Sales Data etc.)
4.2 Koninklijke Philips N.V (Company Profile, Sales Data etc.)
4.3 F. Hoffmann-La Roche Ltd (Company Profile, Sales Data etc.)
4.4 Qiagen (Company Profile, Sales Data etc.)
4.5 Novartis AG (Company Profile, Sales Data etc.)
4.6 Abbott (Company Profile, Sales Data etc.)
4.7 Thermo Fisher Scientific (Company Profile, Sales Data etc.)
4.8 Opko Health (Company Profile, Sales Data etc.)
4.9 Myriad Genetics (Company Profile, Sales Data etc.)
4.10 Agilent Technologies (Company Profile, Sales Data etc.)
4.11 GE Healthcare (Company Profile, Sales Data etc.)
4.12 PerkinElmer (Company Profile, Sales Data etc.)
4.13 Genomic Health (Company Profile, Sales Data etc.)
4.14 Illumina (Company Profile, Sales Data etc.)
4.15 Hologic (Company Profile, Sales Data etc.)
4.16 Almac Group (Company Profile, Sales Data etc.)
4.17 Janssen Global Services (Company Profile, Sales Data etc.)
4.18 Sysmex Corporation (Company Profile, Sales Data etc.)
5 Market Competition
5.1 Company Competition
5.2 Regional Market by Company
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospitals
6.1.2 Demand in Clinics
6.1.3 Demand in Others
6.2 Regional Demand Comparison
6.3 Demand Forecast
7 Region Operation
7.1 Regional Production
7.2 Regional Market
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
7.3.1.2 by Country (U.S., Canada, Mexico)
7.3.2 Europe
7.3.2.1 Overview
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
7.3.3 Asia-Pacific
7.3.3.1 Overview
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
7.3.4 South America
7.3.4.1 Overview
7.3.4.2 by Country (Brazil, Argentina etc.)
7.3.5 Middle East & Africa
7.3.5.1 Overview
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
9 Research Conclusion
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.